Gene Therapy in Treating Patients With Advanced Head and Neck Cancer
Completed · Phase 1
Conditions studied: Head and Neck Cancer
In brief
RATIONALE: Gene therapy may kill cancer cells by inhibiting a gene that promotes the development and growth of cancer. PURPOSE: Phase I trial to study the effectiveness of gene therapy in treating patients who have advanced head and neck cancer.
Key facts
- Study ID
- NCT00009841
- Run by
- University of Pittsburgh
- People needed
- 13
- Starts
- 1999-03-01
- Expected to finish
- 2002-03-01
- Last updated by the study team
- 2016-02-12
Who can join
Age: 18 and older, up to 120. Sex: any. Healthy volunteers: not accepted.
Where it is running
- University of Pittsburgh Cancer Institute — Pittsburgh, Pennsylvania, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.